Skip to main content
. 2021 Jul 11;21:685. doi: 10.1186/s12913-021-06718-4

Table 1.

Effectiveness of the intervention on the proportion of subjects with undetected viral load (≤20 copies/ml) (N = 246)

Intervention Control P-value
Number with undetected viral load (%) Change over 12 months
(E12–E0)
Number with undetected viral load (%) Change over 12 months (E12 – E0)
At baseline 26/119 (21.8%) 54/127 (42.5%) < 0.001
At 12 months 38/119 (31.9%) 10.1% 52/127 (40.9%) −1.6% 0.15
At 12 months adjusteda 28/77 (36.4%) 14.6% 27/56 (48.2%) 5.7% 0.12

aAdjusted for study participants with regimen change to Dolutegravir-based combination